208165-95-1

Usage

Uses

Used in Pharmaceutical Industry:
5-Bromo-2-fluoro-4-nitrotoluene is used as an intermediate in the synthesis of more complex pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Materials Industry:
5-Bromo-2-fluoro-4-nitrotoluene is used as a research chemical for the development of new materials with specific properties. Its reactivity and the presence of various functional groups make it a valuable component in the creation of advanced materials for various applications.
Used in Research Applications:
5-Bromo-2-fluoro-4-nitrotoluene is used as a research chemical to study its reactivity, properties, and potential applications in various fields, including chemistry, materials science, and pharmaceuticals. Its unique structure provides opportunities for exploring new reactions and syntheses.

Upstream product

• 51437-00-4 5-bromo-2-fluorotoluene 

Relevant academic research and scientific papers

Preparation method of o-acetamidobenzenebutyric acid compound

The invention discloses a preparation method of an o-acetamidobenzenebutyric acid compound. The o-acetamidobenzenebutyric acid compound is prepared through a reaction route as shown in a formula A, wherein R1 represents a C1-6 alkyl group, R2 represents a

Pyridonecarboxylic acid derivatives or salts thereof and drugs containing the same as the active ingredient

PCT No. PCT/JP97/04326 Sec. 371 Date May 28, 1999 Sec. 102(e) Date May 28, 1999 PCT Filed Nov. 27, 1997 PCT Pub. No. WO98/23592 PCT Pub. Date Jun. 4, 1998The invention relates to pyridonecarboxylic acid derivatives represented by the general formula (1): wherein R1 is -OH, a carboxy-protecting group or (alkyl)amino group, R2 is H, or -NO2, (protected) amino, (protected) hydroxyl, lower alkyl or lower alkoxyl group, R3 is a halogen atom, H, or -NO2, lower alkyl, lower alkoxyl or amino group, R4 is an azido, (substituted) hydrazino, (substituted) amino, lower alkoxyl or hydroxyl group, R5, R6 and R7 are independently H, -NO2, halogen atom or lower alkyl group, R8 is a -NO2, (substituted) amino, -OH or lower alkoxyl group, A is N or C-R12, in which R12 is H, halogen atom, or (substituted) lower alkyl, lower alkenyl, lower alkynyl, lower alkoxyl, lower alkylthio or nitro group, and B is N or C-R13, in which R13 is H or halogen atom, or salts thereof, and medicine comprising such a compound as an active ingredient. The derivatives or the salts thereof exhibit excellent antibacterial action and peroral absorbability, scarcely cause side effects, and are easy of synthesis.